TRIM19 is more commonly known as the promyelocytic leukaemia (PML) protein as it was originally identified as part of a balanced translocation with retinoic acid receptor α (RARα) that specifically occurs in acute promyelocytic leukaemia (APL) (de The et al. 1991). The gene discussed is RARA; the disease is acute promyelocytic leukemia.